Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Feature|Articles|March 5, 2026
“Canary in the Coal Mine:” Navigating the 2026 Measles Resurgence After Eliminating the Disease
Author(s)Brian Nowosielski
Pharmacists are taking the lead to combat misinformation on measles and preserve the nation’s fragile elimination status.
Advertisement
Advertisement
For decades, the US stood as a global leader in public health, having declared measles eliminated in 2000.1,2 Today, that status is under the most severe threat in a generation.
Related to this article
Approval was given to GSK, making its product the first antisense oligonucleotide established for the treatment of chronic hepatitis B.
The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.
The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.
Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.
Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.
Data assessing Novo Nordisk’s investigational diabetes and obesity medication were presented at The Menopause Society's 2026 Annual Meeting.
Eli Lilly released phase 2b trial results comparing the investigational eloralintide-tirzepatide combo with tirzepatide 15 mg alone in patients with T2D and obesity.
Advertisement
Advertisement